Visual field constriction and antiepileptic drug treatment

Neurology Psychiatry and Brain Research

Volumn 7, Issue 4, 2000, Pages 185-190

  Stefan, H ^a   Bernatik, J ^b   Knorr, H L J ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NONE

Author keywords

Antiepileptic drugs; Epilepsies; Visual field constriction; Visual field defects

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLORAZEPATE; DIAZEPAM; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SULTIAME; TRIMETHADIONE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; EPILEPSY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIMETRY; PRIORITY JOURNAL; VISUAL FIELD DEFECT;

EID: 0033932978     PISSN: 09419500     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Arndt CF, Derambure P, Defoort-Dhellemes S, Hache JC (1999) Outer retinal dysfunction in patients treated with vigabatrin. Neurology 52:1201-1205
2. Backstrom JT, Hinkle RL (1997) Manufacturers have started several studies. BMJ 314:1693
3. Bayer A, Thiel HJ, Zrenner E, Paulus W, Ried S, Schmidt D (1995) Sensitive physiological tests for ocular side-effects of drugs. Ophtalmologe (Antiepileptics) 92:182-190
4. Beran R, Currie J, Sanbach J, Plunkell M (1998) Visual field constriction with new antiepileptic medication. Epilepsia 31(Suppl 26):..-..
5. Blackwell N, Hayllar J, Kelly G (1997) Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing. BMJ 314:1693
6. Cascairo MA, Stewart WC, Sutherling SE (1991) Influence of missed catch trials on the visual field in normal subjects. Graefes Arch Clin Exp Ophthalmol 229:437-441
7. Dieterle LE, Becker W, Berg PA, Reinshagen G (1994) Allergische Vaskulitis durch Vigabatrin. Nervenarzt 65:122-124
8. Eke T, Talbot JF, Lawden MC (1997). Severe persistent visual field contriction associated with vigabatrin. BMJ 314:180-181
9. Elder, M. (1992). Diazepam and it's effects and visual fields. Aust N Z J Ophtalmol 20:267-270
10. Gümbel H, Rosenkranz C, Enzensberger W, Noack H, Martinez C (1997) Pilot study to investi-gate the prevalence of visual field defects in epilepsy patients treated with antiepileptic drugs other than vigabatrin. Hoechst Marion Roussell, Frankfurt/M (internal report)
11. Harding G (1998) Severe persistent visual field constriction associated with vigabatrin. BMJ 316:232-233
12. Harding G, Laweden M, Wild J, Betts TS, Hope-Ross M (1997) Visual defects in patients receiving AEDs. J. Veith Hoechst Marion Roussell. Vigabatrin and peripheral visual field defects. Experiences from the Hoechst Marion Roussell Drug Surveillance Database.
13. Kalviäinen R, Nousianinen I, Nikoskelainen E, Partanen J, Partanen K, Mäntyjärvi M, Riekkinen PJS (1998) Visual field defects associated with initial vigabatrin monotherapy as compared with initial monotherapy. Epilepsia 39:2-5
14. Krämer G, Scollo-Lavizzari G, Jallon P, Blankenhorn V, Goumaz M, Bacher M, Bredel-Geißler A, Kaiser H (1997) Vigabatrin-associated bilateral concentric visual field defects in four patients. Epilepsia, 38 (Suppl 8):5035
15. Krauss GL, Johnson MA, Miller R (1998) Vigabatrin associated retinal cone system dysfunction electroretinogram and ophtalmologie findings. Neurology 60:1-9
16. Lorenz R, Cook H (1988) Visuelle Störungen durch Diphenylhydantoin: Klinische und elektro-ophtalmologische Befunde. Klin Monatsbl Augenheilkd 192:244-248
17. Mackenzie R, Klistorner A (1998). Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ 316:232
18. Malmgren K, Frisen L, Ben-Menachem E (1999) Visual field constriction in a population of epilepsy surgery candidates with and without vigabatrin treatment. Epilepsia, 40 (Suppl 7):110
19. Martinez C, Noack H (1997) The risk of visual field defects and the use of vigabatrin. Denharn Hoechst Marion Roussell (internal report)
20. Nielsen NV, Syversen K (1986). Possible retinotoxic effects of carbamazepine. Acta Ophthalmol 64:278-290
21. Niggling NV, Syversen K (1986). Possible retinotoxic effects of carbamazepine. Acta Ophtalmol 64:278-290
22. Paulus W, Schwarz G, Steinhoff BJ (1996) The effect of anti-epileptic drugs on visual percep-tion in patients with epilepsy. Brain 119:539-549
23. Rao GP, Leach JP, Baterbury M (1998) Study is needed of visual field defects associated with any long term antiepileptic drug. BMJ 317:206
24. Sabril Neuro-ophthalmology Advisory Panel - SNAP (1997) Summary of the meeting of 3rd-4th October, London
25. Stefan H, Bernatik J, Knorr J (1999) Gesichtsfeldstörungen bei Antiepileptikabehandlung. Nervenarzt 70:552-555
26. Steinhoff GJ (1998) New measurements of efficiency and toxicity. In: Stefan H, Krämer G, Mamoli B (eds) Challenge Epilepsy - New Antiepileptic Drugs. Blackwell, Berlin Wien Oxford, 151-164
27. Wilson EA, Brodie MJ (1997) Severe persistent visual field constrictions associated with vigabatrin. BMJ 314:1693
28. Wong ICK, Mawer GE, Sander JWA (1997) Reaction might be dose dependent. BMJ 314:1693